4EZ5 | pdb_00004ez5

CDK6 (monomeric) in complex with inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.70 Å
  • R-Value Free: 
    0.287 (Depositor), 0.297 (DCC) 
  • R-Value Work: 
    0.216 (Depositor) 
  • R-Value Observed: 
    0.220 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 4EZ5

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors.

Cho, Y.S.Angove, H.Brain, C.Chen, C.H.Cheng, H.Cheng, R.Chopra, R.Chung, K.Congreve, M.Dagostin, C.Davis, D.J.Feltell, R.Giraldes, J.Hiscock, S.D.Kim, S.Kovats, S.Lagu, B.Lewry, K.Loo, A.Lu, Y.Luzzio, M.Maniara, W.McMenamin, R.Mortenson, P.N.Benning, R.O'Reilly, M.Rees, D.C.Shen, J.Smith, T.Wang, Y.Williams, G.Woolford, A.J.Wrona, W.Xu, M.Yang, F.Howard, S.

(2012) ACS Med Chem Lett 3: 445-449

  • DOI: https://doi.org/10.1021/ml200241a
  • Primary Citation Related Structures: 
    4AUA, 4EZ5

  • PubMed Abstract: 

    Herein, we describe the discovery of potent and highly selective inhibitors of both CDK4 and CDK6 via structure-guided optimization of a fragment-based screening hit. CDK6 X-ray crystallography and pharmacokinetic data steered efforts in identifying compound 6, which showed >1000-fold selectivity for CDK4 over CDKs 1 and 2 in an enzymatic assay. Furthermore, 6 demonstrated in vivo inhibition of pRb-phosphorylation and oral efficacy in a Jeko-1 mouse xenograft model.


  • Organizational Affiliation
    • Novartis Institutes for Biomedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Macromolecule Content 

  • Total Structure Weight: 35.5 kDa 
  • Atom Count: 2,098 
  • Modeled Residue Count: 258 
  • Deposited Residue Count: 307 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Cyclin-dependent kinase 6307Homo sapiensMutation(s): 0 
Gene Names: CDK6CDKN6
EC: 2.7.11.22
UniProt & NIH Common Fund Data Resources
Find proteins for Q00534 (Homo sapiens)
Explore Q00534 
Go to UniProtKB:  Q00534
PHAROS:  Q00534
GTEx:  ENSG00000105810 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ00534
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
0RS

Query on 0RS



Download:Ideal Coordinates CCD File
B [auth A]{5-[4-(dimethylamino)piperidin-1-yl]-1H-imidazo[4,5-b]pyridin-2-yl}[2-(isoquinolin-4-yl)pyridin-4-yl]methanone
C28 H27 N7 O
VSHURSPEQITHNX-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
0RS BindingDB:  4EZ5 IC50: 300 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.70 Å
  • R-Value Free:  0.287 (Depositor), 0.297 (DCC) 
  • R-Value Work:  0.216 (Depositor) 
  • R-Value Observed: 0.220 (Depositor) 
Space Group: I 4
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 102.478α = 90
b = 102.478β = 90
c = 59.987γ = 90
Software Package:
Software NamePurpose
d*TREKdata scaling
d*TREKdata reduction
PHENIXrefinement
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2013-02-06
    Type: Initial release
  • Version 1.1: 2014-09-24
    Changes: Database references
  • Version 1.2: 2018-01-24
    Changes: Experimental preparation
  • Version 1.3: 2023-09-13
    Changes: Data collection, Database references, Derived calculations, Refinement description